Evofem Biosciences Inc. Shares Close the Week 37.1% Lower - Weekly Wrap

The company saw its shares close the week 37.1% lower than last week, with trading volume higher than its 30 day average.

Mar 26, 2021 by Kwhen Finance Editors

Evofem Biosciences Inc. Shares Close the Week 37.1% Lower - Weekly Wrap
Evofem Biosciences Inc. shares closed this week 37.1% lower than it did at the end of last week. The stock is currently down 29.0% year-to-date, down 61.1% over the past 12 months, and up 144.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.8%, and the S&P 500 fell 0.1%.

Trading Activity

  • Shares traded as high as $2.75 and as low as $1.70 this week.
  • Shares closed 7e+1% below its 52-week high and 1e+1% above its 52-week low.
  • Trading volume this week was 407.8% higher than the 10-day average and 421.4% higher than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 0.6.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
  • MACD, a trend-following momentum indicator, indicates a downward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.
  • The stock closed at 16.4% lower than its 5-day moving average, 31.9% lower than its 20-day moving average, and 33.2% lower than its 90-day moving average.

Market Comparative Performance

  • The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and beats it on a 5-year basis
  • The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and beats it on a 5-year basis
  • The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and beats it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Evofem Biosciences Inc.9.4-29.0-61.1-74.53.6
Dow Jones Industrial Average1.47.156.9-1.461.3
S&P 500 Index1.64.660.4-1.562.9
Health Care1.91.144.6-3.841.1

Peer Group Comparative Performance

  • The company's stock price performance year-to-date lags the peer average by 136.7%
  • The company's stock price performance over the past 12 months lags the peer average by 1252.3%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Evofem Biosciences Inc.EVFM0-29.0-61.1-74.53.6
Peer AvgN/A-2.2-12.3-4.5-27.432.5
Omeros CorporationOMER-8.634.870.7-17.3113.2
Odonate Therapeutics Inc.ODT0-83.9-88.8-92.416.9

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: